Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.50    -0.50 (-0.20%)
Bid:
245.00
Ask:
248.00
Spread: 3.00 (1.224%)
Market Cap: £143.22m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Performance Share Plan award to Directors/PDMRs

12 Nov 2019 15:40

RNS Number : 1678T
MJ Gleeson PLC
12 November 2019
 

12 November 2019

 

MJ Gleeson plc ("Gleeson" or the "Company")

 

Performance Share Plan award to Directors/PDMRs

 

The Company announces that on 11 November 2019 Stefan Allanson, Chief Financial Officer, exercised share options ("Share Options") over 73,531 ordinary shares of 2 pence each in the capital of the Company ("Ordinary Shares") in connection with the Company's Long Term Incentive Plan ("LTIP").

 

Application has been made for the admission to trading of the new Ordinary Shares, which rank pari passu in all respects with the Company's existing Ordinary Shares, on the Main Market of the London Stock Exchange and to listing on the Official List of the UKLA, with dealings expected to commence on or around 15 November 2019.

 

Subsequent to the exercise and issue of the new Ordinary Shares, the Company has been notified that Stefan Allanson sold 34,663 Ordinary Shares at a price of £8.00 per Ordinary Share in order to satisfy tax liabilities resulting from the exercise of the above-mentioned options. Following the exercise and the sale, Stefan Allanson's shareholding has increased to 55,765 Ordinary Shares in the Company, representing 0.1 per cent. of the total voting rights in the Company.

 

Total Voting Rights

Following the issue of the new Ordinary Shares the total number of issued Ordinary Shares is 54,675,284. The Company does not hold any Ordinary Shares in Treasury.

 

Therefore, the total number of Ordinary Shares with voting rights is 54,675,284 which may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's DTR.

 

Enquiries:

MJ Gleeson plc Tel: 44 1142 612 900

James Thomson Interim Chief Executive Officer

Stefan Allanson Chief Financial Officer

 

Instinctif Partners Tel: 44 20 7457 2020

Mark Garraway

James Gray

 

N+1 Singer Tel: 44 20 7496 3000

Shaun Dobson

Rachel Hayes

 

Liberum Tel: 44 20 3100 2222

Neil Patel

Richard Bootle

 

The following notifications are intended to satisfy the Company's obligations under Article 19(3) of EU Regulation No 596/2014 (the Market Abuse Regulation).

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Stefan Allanson

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

MJ Gleeson plc

b)

 

LEI

 

21380064K7N2W7FD6434

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 2 pence each

 

 

GB00BRKD9Z53

b)

 

Nature of the transaction

 

 

Exercise of Share Options

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

Nil (exercise of options)

73,531

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

n/a

e)

 

Date of the transaction

 

 

11 November 2019

f)

 

Place of the transaction

 

 

Off market

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 2 pence each

 

 

GB00BRKD9Z53

b)

 

Nature of the transaction

 

 

Sale of Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

800p

34,663

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

n/a

e)

 

Date of the transaction

 

 

11 November 2019

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKBDNPBDDODD
Date   Source Headline
30th Apr 20137:00 amRNSTotal Voting Rights
18th Apr 201311:41 amRNSHolding(s) in Company
9th Apr 20134:11 pmRNSDirector/PDMR Shareholding
2nd Apr 20137:00 amRNSTotal Voting Rights
6th Mar 20133:15 pmRNSDirector/PDMR Shareholding
28th Feb 20137:00 amRNSHalf Yearly Report
28th Feb 20137:00 amRNSTotal Voting Rights
6th Feb 20134:55 pmRNSDirector/PDMR Shareholding
31st Jan 20137:00 amRNSTotal Voting Rights
11th Jan 20137:00 amRNSTrading Statement
8th Jan 201311:03 amRNSDirector/PDMR Shareholding
31st Dec 20127:00 amRNSTotal Voting Rights
7th Dec 201212:02 pmRNSResult of AGM
7th Dec 201211:00 amRNSAGM Statement
6th Dec 20124:25 pmRNSDirector/PDMR Shareholding
30th Nov 20127:00 amRNSTotal Voting Rights
16th Nov 20127:00 amRNSInterim Management Statement
9th Nov 20129:15 amRNSHolding(s) in Company
7th Nov 20124:26 pmRNSPerformance Share Plan award to Director
5th Nov 20124:04 pmRNSDirector/PDMR Shareholding
31st Oct 20127:00 amRNSTotal Voting Rights
15th Oct 20122:15 pmRNSAdditional Listing
15th Oct 20121:57 pmRNSDirector/PDMR Shareholding
8th Oct 20122:40 pmRNSDirector/PDMR Shareholding
1st Oct 20127:00 amRNSTotal Voting Rights
21st Sep 20127:00 amRNSFinal Results
7th Sep 20129:37 amRNSDirector/PDMR Shareholding
31st Aug 20127:00 amRNSTotal Voting Rights
7th Aug 20124:06 pmRNSDirector/PDMR Shareholding
31st Jul 20127:00 amRNSTotal Voting Rights
9th Jul 20127:00 amRNSDirector/PDMR Shareholding
4th Jul 20127:00 amRNSTrading Statement
2nd Jul 20127:00 amRNSDirectorate Change
29th Jun 20127:00 amRNSTotal Voting Rights
8th Jun 20123:10 pmRNSDirector/PDMR Shareholding
31st May 20127:00 amRNSTotal Voting Rights
11th May 20124:40 pmRNSSecond Price Monitoring Extn
11th May 20124:35 pmRNSPrice Monitoring Extension
11th May 20127:00 amRNSInterim Management Statement
10th May 201211:56 amRNSDirector/PDMR Shareholding
30th Apr 20127:00 amRNSTotal Voting Rights
13th Apr 20124:35 pmRNSPrice Monitoring Extension
11th Apr 201210:40 amRNSDirector/PDMR Shareholding
30th Mar 20127:00 amRNSTotal Voting Rights
7th Mar 20129:17 amRNSDirector/PDMR Shareholding
29th Feb 20121:42 pmRNSHolding(s) in Company
29th Feb 20127:00 amRNSTotal Voting Rights
27th Feb 201212:29 pmRNSHolding(s) in Company
22nd Feb 20127:00 amRNSHalf Yearly Report
15th Feb 20124:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.